Anti-SEC22C monoclonal antibody

Pre-made anti-SEC22C monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SEC22C/SEC22C products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1596-Ab-1/ GM-Tg-hg-IP1596-Ab-2Anti-Human SEC22C monoclonal antibodyHuman
GM-Tg-rg-IP1596-Ab-1/ GM-Tg-rg-IP1596-Ab-2Anti-Rat SEC22C monoclonal antibodyRat
GM-Tg-mg-IP1596-Ab-1/ GM-Tg-mg-IP1596-Ab-2Anti-Mouse SEC22C monoclonal antibodyMouse
GM-Tg-cynog-IP1596-Ab-1/ GM-Tg-cynog-IP1596-Ab-2Anti-Cynomolgus/ Rhesus macaque SEC22C monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1596-Ab-1/ GM-Tg-felg-IP1596-Ab-2Anti-Feline SEC22C monoclonal antibodyFeline
GM-Tg-cang-IP1596-Ab-1/ GM-Tg-cang-IP1596-Ab-2Anti-Canine SEC22C monoclonal antibodyCanine
GM-Tg-bovg-IP1596-Ab-1/ GM-Tg-bovg-IP1596-Ab-2Anti-Bovine SEC22C monoclonal antibodyBovine
GM-Tg-equg-IP1596-Ab-1/ GM-Tg-equg-IP1596-Ab-2Anti-Equine SEC22C monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1596-Ab-1/ GM-Tg-hg-IP1596-Ab-2; GM-Tg-rg-IP1596-Ab-1/ GM-Tg-rg-IP1596-Ab-2;
GM-Tg-mg-IP1596-Ab-1/ GM-Tg-mg-IP1596-Ab-2; GM-Tg-cynog-IP1596-Ab-1/ GM-Tg-cynog-IP1596-Ab-2;
GM-Tg-felg-IP1596-Ab-1/ GM-Tg-felg-IP1596-Ab-2; GM-Tg-cang-IP1596-Ab-1/ GM-Tg-cang-IP1596-Ab-2;
GM-Tg-bovg-IP1596-Ab-1/ GM-Tg-bovg-IP1596-Ab-2; GM-Tg-equg-IP1596-Ab-1/ GM-Tg-equg-IP1596-Ab-2
Products NameAnti-SEC22C monoclonal antibody
Formatmab
Target NameSEC22C
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SEC22C monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1596-Ag-1Recombinant multi-species SC22C/ SEC22C/ SEC22L3 protein


    Target information

    Target IDGM-IP1596
    Target NameSEC22C
    Gene ID9117,215474,687022,716351,485615,101096098,614905,100055103
    Gene Symbol and Synonyms4932412K21,5930407I15Rik,C530046H07,SEC22C,SEC22L3
    Uniprot AccessionQ9BRL7,Q2YDJ2
    Uniprot Entry NameSC22C_HUMAN,SC22C_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000093183
    Target ClassificationN/A

    The target: SEC22C, gene name: SEC22C, also named as SEC22L3. This gene encodes a member of the SEC22 family of vesicle trafficking proteins. The encoded protein is localized to the endoplasmic reticulum and may play a role in the early stages of ER-Golgi protein trafficking. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Jan 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.